Clene Inc. - ESG Rating & Company Profile powered by AI
This report of Clene Inc. was assembled by All Street Sevva using cutting edge Cognitive Robots. Jump to the end of this page for potential risks for Clene Inc. based on industry, location and marketcap. The ESG score covers seventeen UN Sustainable Development Goals including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Life on Land'.
Clene Inc. in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Clene Inc. | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Clene Inc. have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Clene Inc. disclose current and historical energy intensity?
Sign up for free to unlockDoes Clene Inc. report the average age of the workforce?
Sign up for free to unlockDoes Clene Inc. reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Clene Inc. disclose its ethnicity pay gap?
Sign up for free to unlockDoes Clene Inc. disclose cybersecurity risks?
Sign up for free to unlockDoes Clene Inc. offer flexible work?
Sign up for free to unlockDoes Clene Inc. have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Clene Inc. disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Clene Inc. conduct supply chain audits?
Sign up for free to unlockDoes Clene Inc. disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Clene Inc. conduct 360 degree staff reviews?
Sign up for free to unlockDoes Clene Inc. disclose the individual responsible for D&I?
Sign up for free to unlockDoes Clene Inc. disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Clene Inc. disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Clene Inc. disclose water use targets?
Sign up for free to unlockDoes Clene Inc. have careers partnerships with academic institutions?
Sign up for free to unlockDid Clene Inc. have a product recall in the last two years?
Sign up for free to unlockDoes Clene Inc. disclose incidents of discrimination?
Sign up for free to unlockDoes Clene Inc. allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Clene Inc. issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Clene Inc. disclose parental leave metrics?
Sign up for free to unlockDoes Clene Inc. disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Clene Inc. disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Clene Inc. disclose the pay ratio of women to men?
Sign up for free to unlockDoes Clene Inc. support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Clene Inc. disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Clene Inc. reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Clene Inc. involved in embryonic stem cell research?
Sign up for free to unlockDoes Clene Inc. disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Clene Inc. disclose its waste policy?
Sign up for free to unlockDoes Clene Inc. report according to TCFD requirements?
Sign up for free to unlockDoes Clene Inc. disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Clene Inc. disclose energy use targets?
Sign up for free to unlockDoes Clene Inc. disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Clene Inc. have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Clene Inc.
These potential risks are based on the size, segment and geographies of the company.
Clene Inc., a clinical-stage biopharmaceutical company, focuses on the development of various therapeutics for neurodegenerative diseases. The company has a nanotechnology drug platform for the development of orally administered neurotherapeutic drugs. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company's products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; and NM-PtAu7, a gold-platinum CSN therapeutic. Clene Inc. is based in Salt Lake City, Utah.